Global Liposarcoma Treatment Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 106

Report ID: 3411

Liposarcoma is a cancer of fat cells lying deep within the soft tissues, typically in retroperitoneum or thighs.
Surgical therapy treatment segment is expected to account for major share in global liposarcoma treatment market as it is the choice of treatment recommended by majority of cancer specialists. Most of the physicians do not rely on chemotherapy for the liposarcoma treatment however, it can be used prior to the surgery to reduce the size of the tumor making it the second largest segment in terms of value in global liposarcoma treatment market. Radiation therapy treatment is used to avoid recurrence of the liposarcoma after surgery and contributes a minimal share in global liposarcoma treatment market.
North America is anticipated to lead the global liposarcoma treatment market due to relatively greater prevalence of the disease in the region. APAC and MEA regions are expected to witness steady market growth owing to lack of awareness about the disease.
In 2018, the global Liposarcoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Liposarcoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Liposarcoma Treatment development in United States, Europe and China.

The key players covered in this study
Johnson & Johnson
Pfizer
Eli Lilly
Sanofi SA
Novartis AG
Baxter International
Bristol Laboratories
Teva Pharmaceutical Industries
Mylan N.V
Actavis
Fresenius Kabi
Accord Healthcare
Taro Pharmaceuticals
Sandoz
Bedford Laboratories

Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Surgical Therapy

Market segment by Application, split into
Hospitals
Multispecialty Clinics
Cancer Treatment and Rehabilitation Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Liposarcoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Liposarcoma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Liposarcoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Liposarcoma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Surgical Therapy
1.5 Market by Application
1.5.1 Global Liposarcoma Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Multispecialty Clinics
1.5.4 Cancer Treatment and Rehabilitation Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Liposarcoma Treatment Market Size
2.2 Liposarcoma Treatment Growth Trends by Regions
2.2.1 Liposarcoma Treatment Market Size by Regions (2014-2025)
2.2.2 Liposarcoma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Liposarcoma Treatment Market Size by Manufacturers
3.1.1 Global Liposarcoma Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Liposarcoma Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Liposarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Liposarcoma Treatment Key Players Head office and Area Served
3.3 Key Players Liposarcoma Treatment Product/Solution/Service
3.4 Date of Enter into Liposarcoma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Liposarcoma Treatment Market Size by Type (2014-2019)
4.2 Global Liposarcoma Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Liposarcoma Treatment Market Size (2014-2019)
5.2 Liposarcoma Treatment Key Players in United States
5.3 United States Liposarcoma Treatment Market Size by Type
5.4 United States Liposarcoma Treatment Market Size by Application

6 Europe
6.1 Europe Liposarcoma Treatment Market Size (2014-2019)
6.2 Liposarcoma Treatment Key Players in Europe
6.3 Europe Liposarcoma Treatment Market Size by Type
6.4 Europe Liposarcoma Treatment Market Size by Application

7 China
7.1 China Liposarcoma Treatment Market Size (2014-2019)
7.2 Liposarcoma Treatment Key Players in China
7.3 China Liposarcoma Treatment Market Size by Type
7.4 China Liposarcoma Treatment Market Size by Application

8 Japan
8.1 Japan Liposarcoma Treatment Market Size (2014-2019)
8.2 Liposarcoma Treatment Key Players in Japan
8.3 Japan Liposarcoma Treatment Market Size by Type
8.4 Japan Liposarcoma Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Liposarcoma Treatment Market Size (2014-2019)
9.2 Liposarcoma Treatment Key Players in Southeast Asia
9.3 Southeast Asia Liposarcoma Treatment Market Size by Type
9.4 Southeast Asia Liposarcoma Treatment Market Size by Application

10 India
10.1 India Liposarcoma Treatment Market Size (2014-2019)
10.2 Liposarcoma Treatment Key Players in India
10.3 India Liposarcoma Treatment Market Size by Type
10.4 India Liposarcoma Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Liposarcoma Treatment Market Size (2014-2019)
11.2 Liposarcoma Treatment Key Players in Central & South America
11.3 Central & South America Liposarcoma Treatment Market Size by Type
11.4 Central & South America Liposarcoma Treatment Market Size by Application

12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Liposarcoma Treatment Introduction
12.1.4 Johnson & Johnson Revenue in Liposarcoma Treatment Business (2014-2019)
12.1.5 Johnson & Johnson Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Liposarcoma Treatment Introduction
12.2.4 Pfizer Revenue in Liposarcoma Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Liposarcoma Treatment Introduction
12.3.4 Eli Lilly Revenue in Liposarcoma Treatment Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Sanofi SA
12.4.1 Sanofi SA Company Details
12.4.2 Company Description and Business Overview
12.4.3 Liposarcoma Treatment Introduction
12.4.4 Sanofi SA Revenue in Liposarcoma Treatment Business (2014-2019)
12.4.5 Sanofi SA Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Liposarcoma Treatment Introduction
12.5.4 Novartis AG Revenue in Liposarcoma Treatment Business (2014-2019)
12.5.5 Novartis AG Recent Development
12.6 Baxter International
12.6.1 Baxter International Company Details
12.6.2 Company Description and Business Overview
12.6.3 Liposarcoma Treatment Introduction
12.6.4 Baxter International Revenue in Liposarcoma Treatment Business (2014-2019)
12.6.5 Baxter International Recent Development
12.7 Bristol Laboratories
12.7.1 Bristol Laboratories Company Details
12.7.2 Company Description and Business Overview
12.7.3 Liposarcoma Treatment Introduction
12.7.4 Bristol Laboratories Revenue in Liposarcoma Treatment Business (2014-2019)
12.7.5 Bristol Laboratories Recent Development
12.8 Teva Pharmaceutical Industries
12.8.1 Teva Pharmaceutical Industries Company Details
12.8.2 Company Description and Business Overview
12.8.3 Liposarcoma Treatment Introduction
12.8.4 Teva Pharmaceutical Industries Revenue in Liposarcoma Treatment Business (2014-2019)
12.8.5 Teva Pharmaceutical Industries Recent Development
12.9 Mylan N.V
12.9.1 Mylan N.V Company Details
12.9.2 Company Description and Business Overview
12.9.3 Liposarcoma Treatment Introduction
12.9.4 Mylan N.V Revenue in Liposarcoma Treatment Business (2014-2019)
12.9.5 Mylan N.V Recent Development
12.10 Actavis
12.10.1 Actavis Company Details
12.10.2 Company Description and Business Overview
12.10.3 Liposarcoma Treatment Introduction
12.10.4 Actavis Revenue in Liposarcoma Treatment Business (2014-2019)
12.10.5 Actavis Recent Development
12.11 Fresenius Kabi
12.12 Accord Healthcare
12.13 Taro Pharmaceuticals
12.14 Sandoz
12.15 Bedford Laboratories

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details